Moshe Sarfaty
Chief Executive Officer at LS Biopath, Inc.
Moshe Sarfaty active positions
| Companies | Position | Start | End |
|---|---|---|---|
LS Biopath, Inc.
 LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Director/Board Member | - | - |
| Chief Executive Officer | 31/12/2008 | - | |
| President | - | - | |
| Aristagora VC Israel Management Ltd. | Private Equity Investor | 30/06/2020 | - |
Career history of Moshe Sarfaty
Former positions of Moshe Sarfaty
| Companies | Position | Start | End |
|---|---|---|---|
Krypton Venture Capital Ltd.
 Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Founder | 31/12/2012 | 01/07/2020 |
Training of Moshe Sarfaty
| Yale University | Undergraduate Degree |
Statistics
International
| Israel | 3 |
| United States | 3 |
Operational
| Founder | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Finance | 3 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Krypton Venture Capital Ltd.
Krypton Venture Capital Ltd. Investment ManagersFinance Krypton Venture Capital Ltd. (Krypton Venture Capital) is a venture capital firm founded in 2014 by Moshe Sarfaty. The firm is headquartered in Bnei Brak, Israel. | Finance |
LS Biopath, Inc.
LS Biopath, Inc. Medical SpecialtiesHealth Technology LS Biopath, Inc. provides a solution for real-time imaging of breast cancer surgical margins. The private company is based in Saratoga, CA. Breast-conserving-surgery is the most common treatment for breast tumors, and obtaining tumor-free surgical margins decreases the incidence of local recurrences. The company has developed Clearedge, an intra-operative imaging device that can effectively assess breast tissue margins during breast cancer surgery. The CEO of the company is Moshe Sarfaty. | Health Technology |
| Aristagora VC Israel Management Ltd. | Finance |
- Stock Market
- Insiders
- Moshe Sarfaty
- Experience
